These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results. Fleischer DM; Shreffler WG; Campbell DE; Green TD; Anvari S; Assa'ad A; Bégin P; Beyer K; Bird JA; Brown-Whitehorn T; Byrne A; Chan ES; Cheema A; Chinthrajah S; Chong HJ; Davis CM; Ford LS; Gagnon R; Greenhawt M; Hourihane JO; Jones SM; Kim EH; Lange L; Lanser BJ; Leonard S; Mahler V; Maronna A; Nowak-Wegrzyn A; Oriel RC; O'Sullivan M; Petroni D; Pongracic JA; Prescott SL; Schneider LC; Smith P; Staab D; Sussman G; Wood R; Yang WH; Lambert R; Peillon A; Bois T; Sampson HA J Allergy Clin Immunol; 2020 Oct; 146(4):863-874. PubMed ID: 32659313 [TBL] [Abstract][Full Text] [Related]
9. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. Jones SM; Sicherer SH; Burks AW; Leung DY; Lindblad RW; Dawson P; Henning AK; Berin MC; Chiang D; Vickery BP; Pesek RD; Cho CB; Davidson WF; Plaut M; Sampson HA; Wood RA; J Allergy Clin Immunol; 2017 Apr; 139(4):1242-1252.e9. PubMed ID: 28091362 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy. Dupont C; Burks AW; Fleischer DM; Bee KJ; Chainani S; Sampson HA Expert Rev Clin Immunol; 2024 Jun; 20(6):623-633. PubMed ID: 38323337 [TBL] [Abstract][Full Text] [Related]
11. Ara h 2-specific IgE is superior to whole peanut extract-based serology or skin prick test for diagnosis of peanut allergy in infancy. Keet C; Plesa M; Szelag D; Shreffler W; Wood R; Dunlop J; Peng R; Dantzer J; Hamilton RG; Togias A; Pistiner M J Allergy Clin Immunol; 2021 Mar; 147(3):977-983.e2. PubMed ID: 33483152 [TBL] [Abstract][Full Text] [Related]
12. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. Fleischer DM; Greenhawt M; Sussman G; Bégin P; Nowak-Wegrzyn A; Petroni D; Beyer K; Brown-Whitehorn T; Hebert J; Hourihane JO; Campbell DE; Leonard S; Chinthrajah RS; Pongracic JA; Jones SM; Lange L; Chong H; Green TD; Wood R; Cheema A; Prescott SL; Smith P; Yang W; Chan ES; Byrne A; Assa'ad A; Bird JA; Kim EH; Schneider L; Davis CM; Lanser BJ; Lambert R; Shreffler W JAMA; 2019 Mar; 321(10):946-955. PubMed ID: 30794314 [TBL] [Abstract][Full Text] [Related]
13. Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research. Scurlock AM; Burks AW; Sicherer SH; Leung DYM; Kim EH; Henning AK; Dawson P; Lindblad RW; Berin MC; Cho CB; Davidson WF; Plaut M; Sampson HA; Wood RA; Jones SM; J Allergy Clin Immunol; 2021 Mar; 147(3):992-1003.e5. PubMed ID: 33290772 [TBL] [Abstract][Full Text] [Related]
14. Accurate Prediction of Peanut Allergy in One-Third of Adults Using a Validated Ara h 2 Cutoff. Kansen HM; van Erp FC; Knulst AC; Ehlers AM; Lyons SA; Knol EF; Meijer Y; Otten HG; van der Ent CK; Le TM J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1667-1674.e3. PubMed ID: 33248282 [TBL] [Abstract][Full Text] [Related]
15. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study. Kukkonen AK; Pelkonen AS; Mäkinen-Kiljunen S; Voutilainen H; Mäkelä MJ Allergy; 2015 Oct; 70(10):1239-45. PubMed ID: 26095653 [TBL] [Abstract][Full Text] [Related]
16. Correlations between basophil activation, allergen-specific IgE with outcome and severity of oral food challenges. Song Y; Wang J; Leung N; Wang LX; Lisann L; Sicherer SH; Scurlock AM; Pesek R; Perry TT; Jones SM; Li XM Ann Allergy Asthma Immunol; 2015 Apr; 114(4):319-26. PubMed ID: 25841330 [TBL] [Abstract][Full Text] [Related]
17. Early epitope-specific IgE antibodies are predictive of childhood peanut allergy. Suprun M; Sicherer SH; Wood RA; Jones SM; Leung DYM; Henning AK; Dawson P; Burks AW; Lindblad R; Getts R; Suárez-Fariñas M; Sampson HA J Allergy Clin Immunol; 2020 Nov; 146(5):1080-1088. PubMed ID: 32795587 [TBL] [Abstract][Full Text] [Related]
18. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy. Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R Front Immunol; 2021; 12():786738. PubMed ID: 35197963 [TBL] [Abstract][Full Text] [Related]
19. The combination of Ara h 2-sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy. Carrette M; Couderc L; Bubenheim M; Vidal A; Youssouf A; Boyer O; Marguet C; Martinet J Pediatr Allergy Immunol; 2023 Aug; 34(8):e14007. PubMed ID: 37622254 [TBL] [Abstract][Full Text] [Related]
20. Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial. Sampson HA; Shreffler WG; Yang WH; Sussman GL; Brown-Whitehorn TF; Nadeau KC; Cheema AS; Leonard SA; Pongracic JA; Sauvage-Delebarre C; Assa'ad AH; de Blay F; Bird JA; Tilles SA; Boralevi F; Bourrier T; Hébert J; Green TD; Gerth van Wijk R; Knulst AC; Kanny G; Schneider LC; Kowalski ML; Dupont C JAMA; 2017 Nov; 318(18):1798-1809. PubMed ID: 29136445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]